This Month's TIME Showcase- Dr. Moogeh Baharnooris' Recent Publication
Cost‐Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing‐Remitting Multiple Sclerosis in Canada
Authors:
Moogeh Baharnoori, Virender Bhan, Fraser Clift, Kimberly Thomas, Soukaïna Mouallif, Nicholas Adlard, Philip Cooney, François Blanchette, Barkha P. Patel, Daniel Grima
Journal: The PharmacoEconomics, Published-September 2022.